scispace - formally typeset
R

Robert A. Rosenheck

Researcher at Yale University

Publications -  993
Citations -  58354

Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

The effects of federal versus state funding and academic affiliation on mental health services.

TL;DR: Findings suggest that, unlike findings from the general medical literature, academic affiliation is unrelated to the quality and delivery of mental health care.
Journal ArticleDOI

Generic Fluoxetine and Choice of Antidepressant Medication

TL;DR: Only a small increase was found in the rate of new starts of fluoxetine in the year after its release as a lowcost generic, suggesting there appear to be untapped opportunities to realize savings for antidepressants with appropriate administrative mechanisms and incentives.
Journal ArticleDOI

Psychiatric and Substance Use Disorders and Related Service Use in the Diverse Black Sub-Populations in the United States

TL;DR: In this article, the authors compared the proportions and diverse characteristics of these sub-populations, their mental and substance use diagnoses, and related service use, and concluded that the differences observed in the diverse Black populations of the USA, across measures of mental and physical health, and substances use, deserve attention in future research, policy, and program development.
Journal ArticleDOI

Gender Difference in Substance Use and Psychiatric Outcomes Among Dually Diagnosed Veterans Treated in Specialized Intensive PTSD Programs

TL;DR: No significant gender differences were observed in substance use or PTSD outcomes, despite the extreme minority status of women in VHA programs, suggesting highly vulnerable women can benefit as much as men, even when treatment is not formally tailored to address gender-specific needs.